ADENOSINE INJECTION

The Defense Logistics Agency awarded a single-line delivery order to CARDINAL HEALTH, INC. under the basic IDIQ contract SPE2DX-25-D-8022 for the supply of one unit of ADENOSINE INJECTION, identified by National Stock Number 6505015303307 and National Drug Code 63323-0651-89, at a firm fixed price of $151.90. The delivery, dated July 15, 2026, is FOB destination to USS ILLINOIS SSN-786 at FPO AP 96694, with the contractor responsible for all transportation costs and risks until acceptance by the Government at the delivery point. The contractor is certified as a small business, small disadvantaged business, and women-owned small business, triggering specific federal reporting obligations under FAR 19.102. The order is processed electronically via EDI, with payments to be remitted to the Defense Finance and Accounting Service at P.O. Box 182317, Columbus, OH 43218-2317 under payment code SL4701. All packaging and documentation must clearly reference the basic contract number SPE2DX-25-D-8022 and the delivery order number SPE2D9-26-F-7349, though no specific packaging, preservation, marking, or barcoding standards beyond this identification requirement are detailed. Inspection and acceptance occur at the destination by an authorized Government representative, with compliance governed by the terms of the underlying basic contract and referenced DLAD PROC NOTES C19 and C20 for transportation. The contracting officer is Lisa Quinn, with Michelle Pampel serving as administrative support, and no Contracting Officer’s Representative is named. The contract structure is an indefinite-delivery/indefinite-quantity vehicle with a single, non-optionable delivery, and no amendments, modifications, or explicit special requirements such as security clearances or OCI provisions are indicated in the provided documentation.